Nucala 100MG/ML 1ML 1S
Ended Awarded
- Contract number
- SPE2DX25FKWCV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $9,465
Award facts
- Contract value 100% obligated
- $9,464.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $9,464.50 on September 22, 2025, for the supply of Nucala 100mg/ml 1ml injections. This firm fixed-price delivery order, which has an ultimate completion date of September 23, 2025, is issued under the company's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The funding agency is the Medical Supply Chain, a defense-focused entity, and performance will be completed at the contractor's facility in Park Ridge, Illinois. No set-aside designation was applied to this award.
This delivery order reflects DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, particularly for the Department of Defense healthcare system. Nucala (mepolizumab) is a biologic medication used to treat severe eosinophilic asthma and other eosinophil-driven conditions, making this a specialized pharmaceutical product delivery supporting military health facilities. The company's positioning as a primary vendor for the Defense Logistics Agency's pharmaceutical procurement program underscores its significance in providing direct distribution of prescription drugs and specialty medications to military healthcare sites nationwide.
Quick answers
Who was awarded contract SPE2DX25FKWCV?
SPE2DX25FKWCV was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 22, 2025.
How much is contract SPE2DX25FKWCV worth?
The government has obligated $9,465 on SPE2DX25FKWCV.
Is contract SPE2DX25FKWCV an order under another contract?
Yes. SPE2DX25FKWCV is a delivery order under SPE2DX15D9628, an indefinite delivery contract.
Was contract SPE2DX25FKWCV competed?
The extent of competition for SPE2DX25FKWCV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award